Pen Needle Preference in a Population of Canadians with Diabetes: Results from a Recent Patient Survey

Berard, Lori; Cameron, Brett R.; Woo, Vincent

doi:10.1016/j.jcjd.2014.09.008

Cited by 8 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For people with diabetes, barriers to insulin therapy adherence include the perception that insulin therapy is complicated, fear of hypoglycemia, weight gain, and multiple injections, and the perception that insulin therapy significantly restricts a normal lifestyle [ 9 , 26 ]. However, the use of a device that would facilitate discreet insulin delivery and reduce the number of needle–skin penetrations may offer a solution to some of these barriers [ 27 – 31 ]. Compared with traditional MDI insulin regimens, an individual (eating three meals a day) using the patch can potentially decrease the number of mealtime device needle–skin penetrations over 3 days from nine (or more) to one.…”

Section: Discussionmentioning

confidence: 99%

Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch

et al. 2018

View full text Add to dashboard Cite

IntroductionA basal-bolus insulin regimen is needed to achieve glycated hemoglobin A1c (HbA1c) below 7.0% in people with type 1 (T1D) or type 2 (T2D) diabetes who have significant loss of beta-cell function. Nonadherence to therapy is common and negatively affects the ability to reach treatment goals. We examined patient assessment of a new, wearable mealtime insulin-delivery system (patch) relative to their current mealtime insulin-delivery system (syringe, pen, or pump). The patch is designed to deliver only boluses of fast-acting insulin (no basal insulin), mechanically controlled by the patient.MethodsAdults (n = 101) with T1D or T2D assessed their current mealtime insulin-delivery system and then assessed simulated (no active medication) patch use over a 3-day period. Participants evaluated mealtime insulin-delivery systems using eight measures from five domains (convenience, interference with daily activities, diabetes-related worry, psychological well-being, and overall satisfaction/preference) on the self-administered Insulin Delivery System Rating Questionnaire. User ratings of their current insulin-delivery systems (syringe, pen, pump) were compared with those for the patch by repeated measure analysis of variance and one-sample t tests.ResultsParticipants had significant (p < 0.05) preference for patch over syringe in all eight comparisons, and over pen in five out of eight comparisons, with no significant preference for pen. Although there was a preference for patch over pump in six out of eight comparisons, only one showed a significant preference for patch, and one for pump. Significantly more participants reported that they would like to switch to the patch than continue using a syringe (78% vs 22%) or pen (76% vs 24%) but this difference was not significant for the group using a pump (52% vs 48%).ConclusionsParticipants preferred using the patch over pens and syringes. Its ease of use and discreet method of insulin delivery may contribute to improved patient adherence to mealtime insulin regimens among people currently using injection devices.FundingCalibra Medical

show abstract

Section: Discussionmentioning

confidence: 99%

Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch

et al. 2018

View full text Add to dashboard Cite

show abstract

“…A 4 mm pen needle inserted at 90°is long enough to enter the subcutaneous tissue but short enough to reduce the risk of intramuscular injection, and is therefore considered a safe pen needle for adults and children regardless of age, gender, and/or body mass index [21][22][23][24]. Additionally, in a prior study patients reported preferring shorter 5 mm pen needles as compared to longer 8 mm needles [25]. Only 39% of patients reported leaving the pen needle in their skin for 10 s or longer highlighting a key patient injection error (Fig.…”

Section: Patient Self-injection Behaviour: Pen Needle Lengthmentioning

confidence: 99%

“…Technological advances in needle design have observed that a 4 mm pen needle injected at a 90°angle results in optimal needle depth penetration, therefore reducing the risk of intramuscular injections [29]. New-generation pen needles have also been associated with more positive patient reviews and improved ease of use [30], and in general, shorter needles are the preferred choice for most patients [25]. Pen needle hub design may also support proper injection force [29,30].…”

Section: Role Of New-generation Pen Needle Technology To Support Propmentioning

confidence: 99%

Insulin Injection Practices in a Population of Canadians with Diabetes: An Observational Study

Bari¹,

Corbeil

Farooqui

et al. 2020

Diabetes Ther

Self Cite

View full text Add to dashboard Cite

Introduction: Proper insulin injection technique has demonstrated positive clinical outcomes in patients with diabetes. A Canadianbased practice reflective was undertaken to evaluate the current state of understanding of injection technique practices by patients administering insulin, and the importance physicians place on proper injection technique. Methods: Twenty-four sites across Canada completed a practice profile survey and enrolled adult non-pregnant patients with either type 1 or type 2 diabetes injecting insulin using an insulin pen. Seven areas of proper injection Digital Features To view digital features for this article go to

show abstract

“…Several studies had described that patient preference and satisfaction on the use of insulin pen devices lead to increased patient compliance. [32][33][34] Educators should inform subsequently standardized guidance around insulin including injection sites and method. Incorrect knowledge about insulin injections, for example, needle reuse, of patients with diabetes may lead to lipohypertrophy in the injection area, which increase hypoglycemia risk.…”

mentioning

confidence: 99%